Key facts
- Huma’s last known valuation is $1.3B (Jul 2024).
- It has raised $359.6M; the latest was Later Stage VC in Feb 2026.
- Notable investors include Plug and Play Tech Center, Innovate UK, Samsung NEXT Ventures, Raptor Group, Sony Innovation Fund — 40 tracked in total.
- Status: Privately Held (backing).
- ·The complete investor list — 40 names
- ·Watchlist + deal alerts for Huma
- ·The full record, as it builds
Funding rounds
No funding rounds for Huma are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Huma
Operator of a health technology company intended to advance connected care and accelerate research and therapies. The company combines predictive algorithms, digital biomarkers and real-world data to advance proactive, predictive care and research and offers a blend of medical expertise and has partnered with several leading healthcare institutes to measure and improve outcomes for diseases, enabling healthcare professionals to use data to deliver good health for all.
- Sector
- Healthcare
- HQ
- London, United Kingdom
- Founded
- 2011
- Employees
- 450
- Website
- huma.com/
- Ownership
- Privately Held (backing)
Huma doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Huma shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Huma in its N-PORT filings yet. We sweep new filings monthly.